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Superoxide is the proximal reactive oxygen species (ROS) produced by the mitochondrial respiratory
chain and plays a major role in pathological oxidative stress and redox signaling. While there are tools to
detect or decrease mitochondrial superoxide, none can rapidly and speciﬁcally increase superoxide
production within the mitochondrial matrix. This lack impedes progress, making it challenging to assess
accurately the roles of mitochondrial superoxide in cells and in vivo. To address this unmet need, we
synthesized and characterized a mitochondria-targeted redox cycler, MitoParaquat (MitoPQ) that com-
prises a triphenylphosphonium lipophilic cation conjugated to the redox cycler paraquat. MitoPQ ac-
cumulates selectively in the mitochondrial matrix driven by the membrane potential. Within the matrix,
MitoPQ produces superoxide by redox cycling at the ﬂavin site of complex I, selectively increasing su-
peroxide production within mitochondria. MitoPQ increased mitochondrial superoxide in isolated mi-
tochondria and cells in culture a thousand-fold more effectively than untargeted paraquat. MitoPQ was
also more toxic than paraquat in the isolated perfused heart and in Drosophila in vivo. MitoPQ enables the
selective generation of superoxide within mitochondria and is a useful tool to investigate the many roles
of mitochondrial superoxide in pathology and redox signaling in cells and in vivo.
& 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Superoxide production from respiratory complexes is a major
source of mitochondrial reactive oxygen species (ROS) [1,2].
Within the matrix, superoxide is rapidly converted by Mn super-
oxide dismutase (MnSOD) to hydrogen peroxide, which con-
tributes to oxidative damage in a range of pathologies, including
ischemia/reperfusion injury, diabetes and neurodegeneration [3–
5]. Mitochondria-derived hydrogen peroxide is also a signaling
molecule that transduces redox signals by modifying the activity
of redox-sensitive proteins [6–8]. However, our understanding of
the nuanced roles of mitochondrial superoxide in pathology and
normal physiology is limited, making this an area of intense cur-
rent activity.Inc. This is an open access article u
R.C. Hartley),To investigate the impact of mitochondrial superoxide on pa-
thology and redox signaling, it is vital to be able to manipulate its
levels within mitochondria in cells and in vivo. Selectively de-
creasing mitochondrial superoxide is possible by increasing ex-
pression of the endogenous antioxidant enzyme MnSOD [9,10], or
through the use of targeted antioxidants (e.g. MitoSOD [11]). In
contrast, few methods exist to augment mitochondrial ROS pro-
duction selectively. The homozygous deletion of MnSOD elevates
superoxide levels in mice at birth, but is lethal within a few days
[12]. In MnSOD (þ/) mice, mitochondrial function is disrupted
throughout their lifespan, but this may lead to compensatory
changes that mask the effects of superoxide, and furthermore the
relationship between MnSOD expression and matrix superoxide
levels is unclear [13,14]. Finally, many physiological and patholo-
gical consequences of superoxide occur following its transforma-
tion to hydrogen peroxide, and the rate and extent of this trans-
formation are affected by MnSOD level [15,16]. Mitochondrialnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Rationale for the development of MitoParaquat. MitoParaquat (MitoPQ) is
composed of a redox cycling paraquat moiety, and a hydrophobic carbon chain
linking it to a mitochondria-targeting triphenylphosphonium cation. MitoPQ is
accumulated by mitochondria driven by the plasma (Δψp) and mitochondrial (Δψm)
membrane potentials. Within the matrix, the dicationic viologen component of
MitoPQ is reduced to a radical monocation by one-electron reduction at the ﬂavin
site of complex I. The radical monocation then reacts very rapidly with O2 to
generate superoxide. This localized redox cycling leads to the selective production
of superoxide within the mitochondrial matrix.
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spiratory inhibitors such as rotenone or antimycin [1], but these
disrupt the membrane potential, and ATP, NADH and NADPH
synthesis, making interpretation of experimental results challen-
ging. Exogenous redox cyclers such as paraquat (PQ) [17] or me-
nadione [18] generate superoxide in vivo, however this occurs in
many cell compartments, making it difﬁcult to distinguish effects
due to mitochondrial superoxide.
Therefore we cannot currently increase mitochondrial super-
oxide selectively in cells or in vivo. The ability to enhance super-
oxide production speciﬁcally within mitochondria would trans-
form the investigation of ROS-mediated damage and signaling, and
also facilitate the development of better detection methods. What
is required is a small molecule that generates superoxide only in
the mitochondrial matrix, with negligible production in other
parts of the cell. To generate superoxide we chose derivatives of
the viologen PQ (1,1'-dimethyl-4,4'-bipyridinium dichloride), a
herbicide widely used to increase superoxide production in iso-
lated mitochondria, cells and model organisms [14,17,19]. Within
mammalian mitochondria, the one-electron reduction of PQ at the
ﬂavin site of complex I generates the radical monocation PQþ ,
which goes on to react very rapidly (k 7.7108 M1 s1) with
oxygen to produce superoxide [17,19,20]. Although PQ can in-
crease mitochondrial superoxide formation in vivo, its mitochon-
drial uptake is by a slow and poorly characterized process [19]. As
a result, very high PQ concentrations are required for mitochon-
drial effects, leading to extensive superoxide production at non-
mitochondrial sites [21,22]. Therefore here we sought to develop
PQ derivatives that would be selectively and rapidly accumulated
by mitochondria, thereby generating superoxide only within the
organelle.
Due to their high membrane potential, mitochondria naturally
accumulate cations which either diffuse directly through the mi-
tochondrial inner membrane or cross the membrane facilitated by
a protein [23]. Although PQ is a cation, its high surface charge and
polar interface with water greatly increase the energetic cost for
its movement through the hydrophobic core of the mitochondrial
inner membrane [24]. To mitigate this energetic penalty, we tested
two strategies. The ﬁrst was to increase the hydrophobicity of the
viologen moiety of PQ so as to make its partitioning into the
membrane less unfavorable [23]. The second was to conjugate PQ
to the lipophilic triphenylphosphonium (TPP) cation, which accu-
mulates in mitochondria in response to the mitochondrial mem-
brane potential. This strategy has been used extensively to target
small molecules to mitochondria in cells, tissues and whole ani-
mals [23–26]. Here we report a mitochondria-targeted compound,
MitoParaquat (MitoPQ) (Fig. 1), which can be used to selectively
increase superoxide production within the mitochondrial matrix
in cells and in vivo.1. Materials and methods
1.1. Chemical syntheses
The synthesis of the compounds investigated is outlined in
Fig. 2A and the experimental details are given in the Supple-
mentary Information. The structures of the viologens are shown in
Fig. 2B and of the monoalkylated bipyridines in Fig. 2C.
1.2. Ethics statement
All experiments were approved by the institutional ethical re-
view committee and conform to the UK Home Ofﬁce Guidance on
the Operation of the Animals Scientiﬁc Procedures Act 1986
(HMSO). All procedures were performed in accordance with theGuide for the Care and Use of Laboratory Animals.
1.3. Mitochondrial preparations and incubations
Mitochondria were prepared from the livers and hearts of fe-
male Wistar rats of 10 to 12 weeks of age (Charles River, UK).
Animals were killed by stunning followed by cervical dislocation,
and the liver and heart were removed to ice-cold buffer. Rat liver
mitochondria (RLM) were isolated by homogenization and differ-
ential centrifugation at 4 °C in buffer containing 250 mM sucrose,
5 mM Tris-Cl, and 1 mM EGTA (pH 7.4). Rat heart mitochondria
(RHM) were isolated in the same buffer supplemented with 0.1%
(w/v) fatty acid-free bovine serum albumin. Protein content of the
mitochondrial preparations was determined using the biuret assay
with bovine serum albumin as a standard. Mitochondrial incuba-
tions were performed in KCl buffer [120 mM KCl, 10 mM HEPES,
1 mM EGTA (pH 7.2)], unless stated otherwise. Bovine heart mi-
tochondrial membranes were prepared as described [27] and in-
cubated at 0.2 mg protein/mL in KCl buffer.
1.4. Measurement of mitochondrial uptake of compounds by RP-
HPLC
RLM (1 mg protein/mL) were incubated in 4 mL KCl buffer
supplemented with 5 mM glutamate/malate, the various mono-
alkylated bipyridines or viologens, and methyltriphenyl phos-
phonium (TPMP)7p-triﬂuoromethoxyphenylhydrazone (FCCP)
(1 μM) with shaking at 30 °C. After 3 min mitochondria were
pelleted by centrifugation (7500 x g, 10 min) and the supernatants
were collected and diluted with 100% acetonitrile (ACN), 0.1% tri-
ﬂuoroacetic acid (TFA) to 25% ACN. Mitochondrial pellets were
extracted by vortexing in 250 mL 100% ACN, 0.1% TFA followed by
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Fig. 2. Synthesis and structures of the investigated viologens and monoalkylated bipyridines. (A) Synthetic schemes for: (i) viologens and monoalkylated bipyridines; (ii)
viologens and monoalkylated bipyridines conjugated to TPP. ACN, acetonitrile; Me, methyl; Bipy, bipyridine. (B) Viologens: paraquat (PQ), dodecyl methyl viologen (DMV),
didodecyl viologen (DDV), Mito(C4)paraquat (MitoPQC4), Mito(C10)paraquat (MitoPQ). (C) Monoalkylated bipyridines: N-methylbipyridinium (MBipy), N-dodecylbipyr-
idinium (DBipy), Mito(C4)bipyridinium (Mito(C4)Bipy), Mito(C10)bipyridinium (Mito(C10)Bipy).
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the extract was diluted with 0.1% TFA in water to 25% ACN. All
samples were ﬁltered through a 0.22 mm syringe-driven poly-
vinylidene diﬂuoride ﬁlter (Millex, Millipore) and 1 mL was sepa-
rated by RP-HPLC performed using a Gilson 321 pump ﬁtted with a
C18 column (Jupiter 300 A, Phenomenex) and a Widepore C18
guard column (Phenomenex). HPLC buffers A (0.1% TFA) and B
(90% ACN and 0.1% TFA) were used to generate a gradient: 0–
2 min, 5% B; 2–17 min, 5-100% B; 17–19 min, 100% B; 19–22 min
100–5% B with a ﬂow rate of 1 mL/min. Peaks were detected by
absorbance at 220 nm (UV/Vis 151; Gilson) and Chart 5 software
(AdInstruments) was used to calculate the peak areas. The accu-
mulation ratios (ACRs) of the monoalkylated bipyridines or vio-
logens between the mitochondrial pellets and supernatants were
calculated by normalizing the ratios of the peak areas to their
corresponding volumes: 0.6 mL/mg protein for the mitochondrial
matrix and 4 mL for the supernatant.
1.5. Cell culture
C2C12 (mouse myoblasts cell line; European Collection of An-
imal Cell Cultures), and HCT116 (human colon cancer cell line;
American Type Culture Collection) cells were maintained at 37 °C
in a humidiﬁed 5% CO2 incubator. C2C12 cells were cultured in lowglucose (1000 mg/mL) Dulbecco’s modiﬁed Eagle's medium
(DMEM; Invitrogen) supplemented with 10% (v/v) fetal calf serum,
100 U/mL penicillin and 100 mg/mL streptomycin. HCT116 cells
were cultured in high glucose (4500 mg/mL) DMEM (Invitrogen)
supplemented with 10% (v/v) fetal calf serum, 100 U/mL penicillin
and 100 mg/mL streptomycin. Both cell lines were routinely pas-
saged and maintained at sub-conﬂuence. To assess toxicity, C2C12
or HCT116 cells were seeded in 96 well plates at 10 or 15106
cells per well, respectively. After 6 h fresh medium containing the
test compound was added, and after 24 h cell viability was eval-
uated by measuring lactate dehydrogenase (LDH) release into the
medium using the Roche LDH Cytotoxicity Detection Kit, according
to the manufacturer's instructions.
1.6. Detection of superoxide
Superoxide production in bovine heart mitochondrial mem-
branes was detected by measuring SOD-sensitive coelenterazine
chemiluminescence (2 mM; Calbiochem) [28] detected in a lu-
minometer (Berthold AutoLumatPlus LB 953) with 5 s cumulative
readings taken every 30 s over 5 min incubations at 30 °C [29]. For
incubations with intact mitochondria and cells, aconitase activity
was used to infer superoxide production. Following incubation
with test compounds, mitochondria were harvested by
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scraping followed by centrifugation (7500 x g, 1 min). Pellets were
resuspended in 50 mM Tris-Cl (pH 7.4), 0.6 mM MnCl2 and 2 mM
sodium citrate to prevent further aconitase inactivation, lysed by
sonication (101 s pulse; Q700 sonicator, Qsonica), and snap
frozen on dry ice and stored at 80 °C until they were thawed
rapidly at 30 °C just before assay. Aconitase activity was measured
by a coupled enzyme assay and monitored spectrophotmetrically
(SpectraMax Plus 384; Molecular Devices) as the production of
NADPH at 340 nm [29,30].
1.7. Confocal imaging of ROS production within cells
In C2C12 myoblasts, mitochondrial superoxide and hydrogen
peroxide production were monitored by live cell imaging using the
ﬂuorescent dye MitoSOX (Invitrogen). Nuclei were visualized by
staining with Hoechst 33342 (Invitrogen). C2C12 cells were plated
overnight on glass-bottomed culture dishes (MatTek). Cells were
preloaded with 500 nM MitoSOX and Hoechst 33342 (500 ng/mL)
for 10 min in complete growth medium prior to imaging. Cells
were washed three times with Krebs buffer immediately prior to
imaging. Cells were maintained in Krebs buffer at 37 °C on the
temperature-controlled stage of a Nikon Eclipse Ti confocal mi-
croscope for the duration of the experiment. Images were captured
using a 60x oil immersion lens every 30 s over 20 min. Oxidized
MitoSOX was visualized following excitation at 510 nm and
emission collected with a LP 560 nm ﬁlter. Hoechst 33342 was
visualized by excitation at 405 nm and emission collected using a
DAPI ﬁlter set. Individual cells were tracked through time, and
ﬂuorescence intensity was analyzed using Fiji imaging processing
and analysis software.
1.8. Detection of hydrogen peroxide
The rate of hydrogen peroxide efﬂux from RHM was assayed
using a ﬂuorometric plate reader (SpectraMax GeminiXS; Mole-
cular devices). RHM (0.2 mg protein/mL) were incubated with
50 mM Amplex Red reagent (Invitrogen), 5 U/mL horseradish per-
oxidase, and 5 mM glutamate/malate at 30 °C. Fluorescence of
resoruﬁn was detected by excitation at 570 nm and emission at
585 nm and the response was calibrated against hydrogen per-
oxide standards in the presence of RHM.
1.9. Western blotting
For peroxiredoxin 3 detection, RHM (2 mg protein/mL) were
incubated for 3 min at 30 °C in KCl buffer respiring on 5 mM glu-
tamate/malate, supplemented with MitoPQ, PQ or vehicle control.
At the end of the incubation 100 mM N-ethylmaleimide (NEM)
was added and the incubation continued for a further 5 min. Mi-
tochondria were then pelleted by centrifugation (7500 x g, 3 min)
and the pellet re-suspended in loading buffer lacking reductant
and 20 mg protein separated on a non-reducing 12% SDS-PAGE gel
(BioRad). Proteins were then transferred to a PVDF membrane
using a BioRad TurboBlot transfer apparatus. Equal protein loading
and transfer were veriﬁed with Memcode reversible protein stain
following the manufacturer's protocol (Pierce Biotechnology).
Membranes were blocked with Odyssey Blocking Buffer (LI-COR)
for 2 h at room temperature. Incubation with anti-peroxiredoxin 3
(Prdx3; rabbit polyclonal; 1:1000 v/v dilution; ThermoFisher Sci-
entiﬁc) was performed overnight at 4 °C. The membranes were
visualized using the Odyssey infrared imaging system from LI-COR
Biosciences.
For MnSOD detection, C2C12 cells were lysed in ice-cold buffer
containing 10 mM Tris pH 8.0, 150 mM NaCl, 2 mM EDTA, 2 mM
dithiothreitol, 0.4 mM phenylmethylsulfonylﬂuoride, 40% (v/v)glycerol and 0.5% (v/v) NP40 for 1 h. Samples were sonicated
(101 s; Q700 sonicator, Qsonica). Cell lysates were centrifuged
(13,000 x g for 10 min at 4 °C) and the protein concentration of the
resulting supernatant was determined using the bicinchoninic
protein assay (Pierce Biotechnology) with bovine serum albumin
as a standard. Supernatant (15 mg protein) was run on a 12% SDS-
PAGE gel (BioRad) under reducing conditions. Proteins were then
transferred to PVDF and assessed for MnSOD or VDAC using anti-
MnSOD (rabbit polyclonal; 1:5000 v/v dilution; Abcam) or anti-
VDAC (rabbit polyclonal; 1:1000 v/v dilution; Abcam) as described
above for Prdx3. Memcode reversible protein stain was used to
assess protein loading and transfer.
1.10. Isolated perfused mouse heart experiments
C57BL/6J male mice (25 g, Charles River, UK) were kept in
individually ventilated cages with a 12 h light-dark cycle, con-
trolled humidity and temperature (20–22 °C), fed standard chow
and water ad libitum. Mice were administered terminal anesthesia
via intra-peritoneal pentobarbitone injection (140 mg/kg body
weight). Beating hearts were rapidly excised, cannulated and
perfused in isovolumic Langendorff mode at 80 mm Hg pressure
maintained by a STH peristaltic pump controller feedback system
(AD Instruments, UK), with Krebs-Henseleit (KH) buffer con-
tinuously gassed with 95% O2/5% CO2 (pH 7.4, 37 °C) containing (in
mM): NaCl 116, KCl 4.7, MgSO.7H2O 1.2, NaHCO3 25, KH2PO4 1.2,
CaCl2 1.4, glucose 11 [31]. Hearts were continuously paced at
550 bpm and cardiac function was assessed using a ﬂuid-ﬁlled
cling-ﬁlm balloon inserted into left ventricle (LV) connected via a
line to a pressure transducer and a Powerlab system (AD Instru-
ments, UK). The volume of the intraventricular balloon was ad-
justed using a 1.0 mL syringe to achieve an initial LV diastolic
pressure (LVDP) of 4–9 mmHg [31]. Functional parameters (sys-
tolic pressure, end diastolic pressure, heart rate, coronary ﬂow,
perfusion pressure) were recorded using LabChart software v.7
(AD Instruments, UK) throughout the experiment [31]. LVDP was
calculated from the difference between systolic (SP) and diastolic
pressures (DP). After 20 min equilibration, hearts were rando-
mized into three groups (n¼6 in each group) for a further 20 min
treatment with: 50 μM PQ, MitoPQ or TPMP in the perfusate. At
the end of all perfusion protocols, hearts were immediately snap
frozen using Wollenberger tongs pre-cooled in liquid nitrogen and
stored at–80 °C until further analysis.
1.11. Drosophila maintenance and experiments
Wild-type Drosophila melanogaster (white Dahomey stock) were
maintained on standard sugar-yeast-agar medium at 25 °C, 65%
humidity on a 12:12 h light:dark cycle [32]. Experimental ﬂies
were raised at constant density from a synchronized egg collec-
tion. 7 day old females were microinjected under gentle CO2 an-
esthesia using a PicoSpritzer III (Parker) as previously described
[33], except that the injection solution contained 10% v/v EtOH or
PQ/MitoPQ from an EtOH stock solution in Ringers buffer [182 mM
KCl, 46 mM NaCl, 3 mM CaCl2, 10 mM Tris-base; pH 7.2 HCl] sup-
plemented with 1 mg/mL Brilliant Blue dye. Following recovery,
injected ﬂies were returned to vials of food, incubated at 25 °C,
and their survival monitored. A total of 60–80 ﬂies were injected
per condition.
1.12. Statistical analysis and experimental design
Data were expressed as mean with S.D. or S.E.M., and P values
calculated using a two-tailed Student's t-test for pairwise com-
parisons. One-way analysis of variance (ANOVA) followed by Tu-
key's post-hoc test was used for multiple comparisons. Statistical
TPMP
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10 nmol TPMP and separated by RP-HPLC on the indicated gradient of increasing
hydrophobicity (Buffer B¼90% ACN, 0.1% TFA). Compound elution was detected by
absorbance at 220 nm and compared to that of TPMP as an internal standard
(dashed line).2. Results and discussion
2.1. Synthesis and hydrophobicity of viologens and monoalkylated
bipyridines
The poor uptake by PQ into mitochondria may be due to the
energetic cost of crossing the hydrophobic core of the mitochon-
drial inner membrane. One way to mitigate this may be to increase
the hydrophobicity of the PQ derivative, as this greatly enhances
the uptake of other dications into mitochondria [24]. We ﬁrst in-
creased the hydrophobicity of the viologen core of PQ by adding
one or two dodecyl groups to generate dodecyl methyl viologen
(DMV) and didodecyl viologen (DDV) with the hope of thereby
decreasing the energy for uptake (Fig. 2B). In an alternative
strategy, we also conjugated a viologen to a TPP cation (Fig. 2B),
which has been widely used to drive uptake into mitochondria of
many molecules, including relatively polar moieties (e.g. [34])
(Fig. 2B). Furthermore, as increasing the hydrophobicity of the TPP
conjugate enhances the uptake of conjugated polar moieties, we
made viologens conjugated to TPP by a 4-carbon linker (Mi-
toPQC4), and with a more hydrophobic 10-carbon linker (MitoPQ)
(Fig. 2B).
We also considered that as the double charge on PQ is likely to
be a major impediment to uptake, a monocation such as a
monoalkyl bipyridine should be taken up more readily and could
be more effective at increasing mitochondrial superoxide than an
impermeable viologen. Although protonated monoalk-
ylbipyridines will redox cycle as effectively as viologens [35,36] at
low pH their low pKa (2.7) means they are far more difﬁcult to
reduce than PQ at neutral pH (Em−800 mV [35] against
Em¼446 mV for PQ [36–38]). To assess whether monoalkylated
bipyridines could be effective mitochondrial redox cyclers we
made N-methylbipyridinium (MBipy) and the more hydrophobic
N-dodecylbipyridinium (DBipy) (Fig. 2C). To assess whether
monoalkylated bipyridines could be effective mitochondrial redox
cyclers we made N-methylbipyridinium (MBipy) and the more
hydrophobic N-dodecylbipyridinium (DBipy) (Fig. 2C). We also
made monoalkylated bipyridines conjugated to a TPP cation by a
4-carbon linker (Mito(C4)Bipy), and one with a more hydrophobic
10-carbon linker (Mito(C10)Bipy) (Fig. 2C).
As the relative hydrophobicities of these compounds is a major
determinant of mitochondrial uptake [24], we next compared their
retention times by RP-HPLC on a C18 column to that of TPMP as an
internal standard (Fig. 3). The order of hydrophobicity is:
MitoPQC4oMito(C4)BipyoMitoPQoMito(C10)
BipyoTPMPoDMVoDBipyoDDV. Therefore we have a series of
viologens and monoalkyl bipyridines with a range of hydro-
phobicities that can be tested to assess their ability as redox cy-
clers within mitochondria.
2.2. Redox cycling by viologen and monoalkylated bipyridines
Redox cycling by PQ relies on its reduction potential
(Em¼446 mV [36]) allowing it to transfer electrons from the
ﬂavin mononucleotide (FMN) site of complex I to oxygen. As
varying the alkyl substituents of dialkylbipyridiniums does not
alter the reduction potential [36], all our viologen derivatives can
in principle redox cycle. However, to be effective redox cyclers
within mitochondria, the viologen and monoalkylated bipyridines
in Fig. 2 have to access the FMN site of complex I [19,20] (Fig. 1). As
this interaction might be disrupted by the bulky alkyl or TPP
groups, we next determined whether the viologen and mono-
alkylated bipyridines could generate superoxide from complex I invitro using mitochondrial membranes incubated with NADH and
rotenone (Fig. 4). These membranes are fragmented and therefore
uptake across a membrane is not required to access complex I [27].
Superoxide production was detected by the SOD-sensitive che-
miluminescence of coelenterazine (CLZ) [28]. NADH and rotenone
led to a basal level of superoxide production that was greatly en-
hanced by PQ and to similar extents by MitoPQC4 and MitoPQ
(Fig. 4). DDV and the monoalkylated bipyridines MBipy and DBipy
led to a smaller increase in superoxide production over that of
NADH, while DMV disrupted complex I, as even basal NADH-de-
pendent superoxide formation was lost (Fig. 4A). In all cases, su-
peroxide production was negligible in the absence of respiratory
substrate (data not shown). To facilitate comparison, we sub-
tracted the background superoxide production, showing that the
viologens PQ, MitoPQC4 and MitoPQ generated similar high levels
of superoxide from complex I, while the alkylated viologen DDV
was far less effective (Fig. 4B). All the monoalkylated bipyridines
were4–15-fold less effective than viologens at generating su-
peroxide. As only a tiny fraction (oo0.1%) will be protonated at
physiological pH (pKa 2.7) the level of redox cycling is un-
expectedly high, perhaps due to an increase in the pKa of the
monoalkylbipyridine upon interacting with the FMN site of com-
plex I.
Therefore we have generated two viologen derivatives con-
jugated to the TPP cation that redox cycle as well as unmodiﬁed
PQ, making them potential mitochondria-targeted redox cyclers.
In addition, we have made monoalkylated bipyridines that are less
effective redox cyclers, but which may still be useful should
010,000
20,000
25,000
+ N
AD
H
MB
ipy
DB
ipy
Mi
to(
C4
)B
ipy
Mi
to(
C1
0)B
ipy PQ DM
V
DD
V
Mi
toP
QC
4
Mi
toP
Q
Monoalkylated 
Bipyridines
Viologens
*
*
*
*
***
*
5,000
10,000
15,000
20,000
A
B
N.D.0
C
LZ
 C
he
m
ilu
m
in
es
ce
nc
e
(R
LU
/s
)
C
LZ
 C
he
m
ilu
m
in
es
ce
nc
e
(R
LU
/s
)
MB
ipy
DB
ipy
Mi
to(
C4
)B
ipy
Mi
to(
C1
0)B
ipy PQ DM
V
DD
V
Mi
toP
QC
4
Mi
toP
Q
Monoalkylated 
Bipyridines
Viologens
– SOD
+ SOD
5,000
15,000
– N
AD
H
Fig. 4. Superoxide generation by redox cycling at complex I in mitochondrial
membranes. (A) Superoxide production in bovine heart mitochondrial membranes
measured by the CLZ chemiluminescence assay. Membranes were incubated with
1 mM NADH and rotenone (4 μg/mL), and supplemented with Cu,Zn-SOD
(100 U/mL) and 1 mM viologens or monoalkylated bipyridines as indicated. Data are
means7S.D. of three independent experiments. npo0.05 compared to NADH/ro-
tenone by Student's t test. (B) The rates of superoxide production corrected for that
in the presence of SOD.
M
ito
P
Q
TP
M
P
Mitos blank
+ FCCP
50
60
%
 B
uf
fe
r B
 
25 s
BA
1
1
2
A
22
0 =
 0
.1
A
cc
um
ul
at
io
n 
R
at
io
Fig. 5. Uptake of compounds by energized mitochondria. (A) RP-HPLC analysis of mitoc
succinate (5 mM), rotenone (4 μg/mL), and with 5 μM MitoPQ and 5 mM TPMP7500 nM
supernatant retained, the pellets were extracted and TPMP and MitoPQ were detected by
ratios for compounds in mitochondria. The indicated compounds (5 mM) were incubate
present in the pellets and supernatants were used to determine an accumulation rati
npo0.05 relative to theþFCCP condition by ANOVA with Tukey’s post hoc test.
E.L. Robb et al. / Free Radical Biology and Medicine 89 (2015) 883–894888greater mitochondrial uptake compensate for diminished redox
cycling.
2.3. MitoPQ is accumulated by energized mitochondria
To enhance superoxide production in mitochondria over PQ,
the newly developed compounds have to accumulate rapidly
within the matrix in response to the membrane potential (Fig. 1).
Therefore we next measured their uptake by energized mi-
tochondria (Fig. 5). After incubation with MitoPQ and TPMP, mi-
tochondria were pelleted and assessed by RP-HPLC, showing ex-
tensive uptake of both MitoPQ and TPMP, which was decreased by
the uncoupler FCCP (Fig. 5A). To quantify uptake, we also mea-
sured the accumulation ratio (ACR), that is the relative amounts of
the compounds in the mitochondria and supernatant. Both TPMP
and MitoPQ had substantial ACRs which were decreased by FCCP
(Fig. 5B). Assessment of the other compounds in the same way
showed that DMV, DBipy, and the TPP-conjugated derivative Mito
(C10)Bipy were all accumulated by energized mitochondria
(Fig. 5B). Interestingly, while MitoPQ and Mito(C10)Bipy were ta-
ken up, MitoPQC4 and Mito(C4)Bipy were not, consistent with
uptake requiring the hydrophobicity provided by the ten carbon
linker to counteract the polar viologen or monalkyl bipyridine
moiety.
The uptake of all the monoalkylated bipyridines, including
those conjugated to TPP, was lower than for TPMP. That DMV and
DDV are taken up, while PQ is not [19], indicates that increasing
the hydrophobicity of the doubly charged viologen core does en-
hance passage through the mitochondrial inner membrane.
Therefore we have redox cycling viologens that are taken up into
mitochondria to a far greater extent than PQ [19].
2.4. MitoPQ stimulates hydrogen peroxide production by isolated
mitochondria
We next investigated whether the compounds taken up by
energized mitochondria could initiate redox cycling within the
matrix. MitoPQ signiﬁcantly increased hydrogen peroxide pro-
duction, the product of superoxide dismutation, from heart mi-
tochondria (Fig. 6A). When this analysis was extended to the other
compounds it showed that, as expected [19], similar concentra-
tions of PQ were ineffective and that DBipy was the only other
compound to increase hydrogen peroxide efﬂux, albeit to a smaller
extent than for MitoPQ (Fig. S1). Therefore, MitoPQ was by far theTP
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tochondria, presumably due to its membrane potential-dependent
accumulation (Fig. 5) and its redox cycling at complex I (Fig. 4).
Consequently we focused on further characterizing ROS produc-
tion by MitoPQ.
MitoPQ was several hundred-fold more potent than PQ at in-
ducing hydrogen peroxide production from isolated mitochondria
(Fig. 6B) and this hydrogen peroxide production was eliminated by
preventing MitoPQ uptake with FCCP (Fig. 6C). To assess super-
oxide formation by MitoPQ more directly within mitochondria, we
measured inactivation of the superoxide-sensitive matrix enzyme
aconitase [30]. MitoPQ was several hundred-fold more potent atdecreasing aconitase activity than PQ (Fig. 6D), and this inactiva-
tion was prevented by FCCP (Fig. 6E). We next monitored the re-
lative amounts of monomeric and dimeric forms of peroxiredoxin
3 (Prdx3). This mitochondrial matrix antioxidant enzyme sca-
venges hydrogen peroxide to form a disulﬁde-bonded dimer, with
the proportion in the monomeric form decreasing as mitochon-
drial hydrogen peroxide increases [39,40]. MitoPQ, but not PQ,
caused the disappearance of monomeric Prdx3, consistent with
increased matrix hydrogen peroxide, and this was prevented by
FCCP (Fig. 6F). Together, these data support the accumulation of
MitoPQ by energized mitochondria driving superoxide production
within the matrix by redox cycling at complex I.
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cells
To see whether MitoPQ could stimulate superoxide production
within mitochondria in cells, we used the increase of ﬂuorescence
of MitoSOX, which responds to elevated superoxide and hydrogen
peroxide in the mitochondrial matrix [41]. MitoPQ increased Mi-
toSOX ﬂuorescence (Fig. 7A), and this oxidation increased over
time (Fig. 7B). In contrast, PQ was unable to increase MitoSOX
oxidation over this timescale, even at a thousand times greater
concentration than used for MitoPQ (Fig. 7C). MitoPQ treatment
for 6 h decreased aconitase activity, while the same concentrationof PQ had no effect (Fig. 7D), also consistent with MitoPQ in-
creasing superoxide production within mitochondria in cells.
To further assess MitoPQ superoxide production within mi-
tochondria in cells, we measured MnSOD expression levels, which
increases as an adaptation to elevated matrix superoxide [42,43].
MitoPQ increased MnSOD protein levels in a time- and dose-de-
pendent manner, reaching a maximal induction of 2-fold at 12 h
(Fig. S2). Quantiﬁcation by scanning densitometry showed that 1–
5 mM MitoPQ increased MnSOD expression, while a thousand-fold
higher PQ concentration was required to enhance expression to
the same extent (Fig. 7E). Higher concentrations of MitoPQ de-
creased MnSOD protein levels, presumably due to mitochondrial
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effect of MitoPQ was conﬁrmed by measuring cell viability, which
showed that MitoPQ increased cell death, while several hundred-
fold higher concentrations of PQ were required to generate com-
parable toxicity (Fig. 7F and Fig. S3). Together these data indicate
that MitoPQ accumulates selectively within mitochondria in cells
to generate superoxide that induces biological responses to ele-
vated superoxide and, at higher concentrations, causes cell death.
2.6. MitoPQ disrupts mitochondrial function in the isolated perfused
heart
We next assessed the effects of MitoPQ on the function of the
isolated perfused heart. For this, we perfused beating mouse
hearts in isovolumic Langendorff mode and functional parameters
(systolic pressure, end diastolic pressure, coronary ﬂow and per-
fusion pressure) were recorded throughout (Fig. 8A-C). Pre-
liminary experiments showed that prolonged perfusion with
500 mM PQ was required to see toxic effects, while 5 mM MitoPQ
was mildly damaging, therefore we assessed the effects of 50 mM
MitoPQ in detail. After equilibration, hearts were randomized for
perfusion with 50 mM MitoPQ, PQ, or TPMP (as a control for non-
speciﬁc effects of lipophilic cations). MitoPQ decreased LVDP
(Fig. 8A), increased end diastolic pressure (Fig. 8B) and decreased
coronary ﬂow (Fig. 8C), with no change in heart rate (data not
shown). In contrast, the same concentrations of PQ or TPMP had
no effect (Fig. 8A-C). These data are consistent with MitoPQ being
far more damaging to heart function than PQ. This heart damage is
due to its selective uptake by mitochondria within the heart and
subsequent oxidative damage to the organelles leading to cell
death and disruption to heart function.
2.7. MitoPQ is toxic to ﬂies in vivo
To extend our study to whole organisms, we exposed wild-type
Drosophila melanogaster to a single bolus of PQ or MitoPQ viamicroinjection, and monitored their survival (Fig. 9D). Over a
range of concentrations, MitoPQ treatment was signiﬁcantly more
toxic to the ﬂies than PQ (Fig. 8D). These data conﬁrm that se-
lective targeting of MitoPQ to mitochondria enhances toxicity re-
lative to PQ in vivo.
2.8. Rationale for the poor uptake of PQ into mitochondria
Having shown that modiﬁcation of PQ by conjugation to a hy-
drophobic TPP cation led to its accumulation by mitochondria, we
next considered the reasons underlying the poor accumulation of
PQ into mitochondria [19,20,29]. Lipophilic cations such as TPP are
rapidly and extensively accumulated by energized mitochondria
due to the membrane potential, but this does not occur for PQ,
despite it being a cation [19,20,29]. Although the two charges on
PQ are delocalized, the dication is very strongly solvated in water
because the charged surface is solvent accessible (Fig. 9A). The
related monocationic N-methylpyridinium (MBipy) also has a
solvent accessible charge (Fig. 9A). On the other hand, steric con-
gestion around the phosphorus atom of the TPP cation in triphe-
nylmethylphosphonium (TPMP) shields the charge from the sol-
vent, making the exposed surface much less polar than that of PQ
(Fig. 9A). The increased solvation of PQ in water compared to TPP
cation will make the energy for uptake across a membrane far
greater for PQ and is the likely explanation for its poor uptake.
To obtain a more quantitative insight into the thermodynamics
of the relative transport of PQ and TPMP fromwater into an apolar,
lipophilic environment, we calculated the free energies for transfer
from water to hexane for TPMP, MBipy and PQ and Cl . Hexane
was chosen because it mimics the hydrophobic core of biological
membranes, which is the most unfavourable environment through
which cations must pass when crossing the membrane. One way
of mitigating this energetic penalty is by cations forming ion pairs
with Cl , the dominant anion present in vivo (Fig. 9B). The details
of the calculations are given in the Supplementary Information
and the results are summarized in Table 1. The relevant free
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the cations from water to hexane, highlighted in bold in Table 1,
are the free energy of transfer of the free ions and the sum of the
free energies of transfer and ion-pairing. These calculations re-
vealed two important effects: ﬁrstly, the energetic penalty for PQ
to move into the non-aqueous hexane phase is more than seven
times greater than that for TPMP; secondly, this penalty is sig-
niﬁcantly reduced when PQ transfers as a neutral ion pair with
two chloride anions, while in contrast ion-pair formation increases
the penalty for TPMP. The energy proﬁle for transport of a lipo-
philic cation across a phospholipid bilayer has local minima closeto the membrane surface and an energy maximum at the core of
the membrane [23], and typical such proﬁles are shown in Fig. 9C.
Thus, the relatively lipophilic TPMP ion (low overall charge, small
surface charge, extended apolar surface area) can transfer as a free
ion from water to hexane at moderate thermodynamic cost and
does not beneﬁt from ion pairing with Cl (Fig. 9C). On the other
hand, for the hydrophilic PQ ion (high overall charge, concentrated
surface charge, little apolar surface area), it is thermodynamically
prohibitive to transfer as a free ion. However, when paired with
counter ions (even a small, hydrophilic one such as Cl), the cost is
signiﬁcantly reduced. Although hexane is more hydrophobic than
Table 1
Free energiesa (in kJ mol1) for the transfer (ΔtG*) of ions and ion pairs from water
(aq) to hexane (Hex), and for ion-pair formation (ΔipG*) in either solvent.
S ΔtGn(S, aq-Hex) ΔipGn(aq) ΔipGn(Hex) ΔipGn(aq)
þΔtGn(S, aq-Hex)
TPMPþ 44
MBipyþ 100
PQ2þ 317
Cl– 157
[TPMPþ  Cl] 39 19 143 58
[MBipyþ  Cl] 71 16 170 88
[PQ2þ  2 Cl] 132 29 470 161
a. Calculated using density-functional theory with a continuum solvent model at
the TPSS-D3/def2-TZVPþ/SMD//TPSS-D3/def2-SVPþ/COSMO level; see Supple-
mentary Information for details.
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above, these calculations provide a plausible explanation for the
poor accumulation of PQ into mitochondria [19,24]. Furthermore,
these considerations suggest that PQ may cross the mitochondrial
inner membrane as a neutral complex with two Cl anions and so
will not accumulate in response to the membrane potential, in
contrast to TPMP. Additionally, even as an ion pair, the partitioning
of PQ into the membrane is still thermodynamically very un-
favorable (Fig. 9C).
This analysis may also shed light on some of the data shown in
Fig. 5. There the mitochondrial uptake of MitoPQ, with a charge of
þ3, was not signiﬁcantly different from that of the monocation
TPMP. This was surprising, as the Nernst equation predicts far
greater mitochondrial uptake for a trication over a monocation
[24]. The explanation may be due to the ion pairing between the
PQ moiety and two Cl anions within the membrane (Fig. 9C),
generating a neutral complex that is then transported into the
mitochondria as a net monocation by the conjugated TPP. How-
ever, we note that DMV and DDV were also taken up by energized
mitochondria, suggesting that the PQ moiety may also be able to
cross the membrane as a singly charged complex with one Cl
anion, provided the overall molecule is sufﬁciently hydrophobic.3. Conclusion
The ability to selectively increase mitochondrial superoxide
production in the mitochondrial matrix in cells and in vivo would
be very useful for investigating mitochondrial free radical pro-
duction in health and disease. Existing methods to elevate mi-
tochondrial superoxide use inhibitors of the electron transport
chain, or redox cycling compounds such as PQ or menadione.
However, the many side-effects of inhibiting mitochondrial re-
spiration render results from these experiments almost impossible
to interpret, while the uncertain intracellular location of redox
cycling by PQ and menadione makes it hard to assign the effects to
mitochondrial superoxide. Here we have developed a mitochon-
dria-targeted viologen, MitoPQ that accumulates rapidly within
mitochondria in cells and in vivo to increase matrix superoxide
levels. While in this study the effects in vivo and in the perfused
organ led to extensive damage, it will be possible to use lower,
non-toxic levels of MitoPQ in the future to assess the effect of
chronic elevation of superoxide. In addition, the increase in su-
peroxide by MitoPQ, in the presence of nitric oxide, will also en-
able the effects of peroxynitrite in vivo to be assessed. The ability
of MitoPQ to achieve rapid and speciﬁc increases in matrixsuperoxide will be useful in the further exploration in cells and
in vivo of the nuanced roles of mitochondrial superoxide produc-
tion in health and disease.Acknowledgements
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